The U.S. Centers for Disease Control and Prevention (CDC) awarded a $4,989,475 Cooperative Agreement under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) to Public Health Foundation Enterprises, Inc. (doing business as Heluna Health), a non-profit organization. The award will provide technical assistance, training, workforce development, and targeted interventions to build the capacity of healthcare organizations, community-based organizations, and...
This $7,888,424 Cooperative Agreement was awarded by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award, effective August 30, 2024 through March 31, 2029, supports two main components: eLearning training for high-impact HIV prevention programs Organization/workforce development and management for community-based organizations The prime recipient, HealthHIV, is a national non-profit...
This $4,989,475 Cooperative Agreement award from the National Center for HIV/AIDS, a program under the Centers for Disease Control and Prevention (CFDA 93.834 - Capacity Building Assistance for High-Impact HIV Prevention), provides capacity building assistance and technical assistance to support high-impact HIV prevention programs aimed at ending the HIV epidemic in the United States. The Regents of the University of California, San Francisco (UCSF) will serve as the primary awardee,...
This federal Cooperative Agreement award from the National Center for HIV/AIDS, part of the Centers for Disease Control and Prevention (CDC), provides $12,784,460 in funding to Health Research, Inc.'s Aids Institute Division from August 1, 2024 to May 31, 2029. The award supports the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) to implement comprehensive HIV prevention and surveillance programs in New York that align with the national Ending the HIV...
The federal Cooperative Agreement award NU65PS923774, provided by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834), will fund $15,351,606.00 in capacity building and technical assistance services from August 2024 to March 2029. The prime awardee, Cicatelli Associates, Inc. (CAI), will deliver a range of services to healthcare organizations, community-based organizations, and state/local health...
The Centers for Disease Control and Prevention (CDC) awarded a $4,989,475 Cooperative Agreement under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) to the Denver Health and Hospital Authority, doing business as Denver Health. The award, which runs from August 30, 2024 to March 31, 2029, will support Denver Health's efforts to build the capacity of healthcare organizations, community-based organizations, and state/local health departments to implement...
This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) provides $1,499,856.00 to the University of Rochester to support trusted school messengers promoting non-mandated vaccination. The project period runs from September 30, 2024 to September 29, 2027. The ELC program aims to enhance public health infrastructure for detecting, responding to, preventing,...
This federal Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834), provides $4,989,475.00 to the City & County of San Francisco Public Health Department to deliver technical assistance and capacity building services for HIV prevention programs across the United States. The award, with a performance period from Aug 30, 2024 to Mar 31, 2029, will support...
This $1,384,843 Cooperative Agreement award from the Centers for Disease Control and Prevention's HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) will provide comprehensive HIV prevention and treatment services targeting high-risk and underserved populations in Montana. The funding will support HIV testing, linkage to medical care, PrEP services, behavioral interventions, and capacity building for healthcare providers. The lead awardee, the Montana...
The federal Cooperative Agreement award of $4,989,475.00 from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) supports the "Capacity Building Assistance (CBA) for High-Impact HIV Prevention" program (CFDA 93.834). This five-year award, effective from August 30, 2024 to March 31, 2029, provides funding to the Latino Commission On Aids Inc., a non-profit organization in New York, to implement evidence-based practices, community outreach, and...
The University of Rochester was awarded a $4,989,476 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The grant, which runs from August 2024 to March 2029, will support the university's efforts to build the capacity of healthcare organizations, community-based organizations, and state/local health departments to implement high-impact HIV prevention initiatives. Key services to be provided include technical assistance, training, workforce development, organizational support, and targeted interventions to address HIV-related health disparities across the United States.